Subscribe To
Hrmy vs. regn: which stock should value investors buy now?
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Harmony Biosciences Holdings, Inc. (HRMY) and
November 3, 2023, 12:47 pm
regeneron reports third quarter 2023 financial and operating results
Third quarter 2023 revenues increased 15% to $3.36 billion versus third quarter 2022 Third quarter 2023 Dupixent® global net sales (recorded by Sanof...
November 2, 2023, 10:30 am
regeneron pharma's adjusted earnings beat estimates
regeneron Pharmaceuticals Inc.'s stock REGN, +1.46% rose fractionally on Thursday after the drug maker ...
November 2, 2023, 6:49 am
regeneron beats quarterly profit estimates on eczema treatment strength
regeneron Pharmaceuticals on Thursday beat Wall Street estimates for third-quarter profit, driven by st...
November 2, 2023, 6:42 am
Curious about regeneron (regn) q3 performance? explore wall street estimates for key metrics
Besides Wall Street's top -and-bottom-line estimates for regeneron (REGN), review projections for some ...
November 1, 2023, 12:47 pm
Libtayo® (cemiplimab) neoadjuvant treatment demonstrates encouraging event-free survival in patients with resectable cutaneous squamous cell carcinoma (cscc)
89% estimated event-free survival at one year among patients with stage II to IV resectable CSCC who received Libtayo prior to surgery in a Phase 2 tr...
October 21, 2023, 12:48 pm
2 healthcare stocks near 52-week highs still worth buying
Healthcare stocks, on balance, haven't been great investments in 2023. regeneron Pharmaceuticals and Ve...
October 16, 2023, 9:26 am
regeneron to showcase progress from innovative oncology portfolio in several difficult-to-treat cancers at esmo
Event-free survival of investigational use of Libtayo® (cemiplimab) in neoadjuvant cutaneous squamous cell carcinoma (CSCC) from Phase 2 trial to be ...
October 15, 2023, 10:05 pm
Will regeneron (regn) beat estimates again in its next earnings report?
regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combinat...
October 6, 2023, 1:32 pm
This market-beating stock just gave investors more reasons to invest
regeneron recently earned a key regulatory approval. The company also expanded its pipeline with an acq...
October 5, 2023, 9:15 am
regeneron, intellia therapeutics expand research collaboration to make gene editing therapies
regeneron Pharmaceuticals and Intellia Therapeutics have expanded their research collaboration to devel...
October 3, 2023, 7:10 am
regeneron to report third quarter 2023 financial and operating results and host conference call and webcast on november 2, 2023
TARRYTOWN, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) — regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) tod...
September 28, 2023, 8:05 pm
regeneron to report third quarter 2023 financial and operating results and host conference call and webcast on november 2, 2023
TARRYTOWN, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) -- regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) toda...
September 28, 2023, 4:05 pm
Fda accepts sanofi's (sny) sbla for dupixent in pediatric eoe
If this filing is approved, Sanofi (SNY)/regeneron's (REGN) Dupixent will be the first FDA-approved tre...
September 26, 2023, 9:46 am
regeneron completes acquisition of decibel therapeutics, adding promising gene therapy programs for hearing loss
TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) — regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) tod...
September 25, 2023, 12:34 pm
This recent fda approval could give regeneron's top line a big boost
regeneron's sales growth rate has been struggling over the past year. Revenue from its top-selling drug...
September 20, 2023, 10:07 am
regeneron pharmaceuticals: game-changing discoveries in healthcare
regeneron Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Tarrytown that has played ...
September 19, 2023, 2:45 pm
Decibel therapeutics' cvr appears around fair value
Decibel Therapeutics is being acquired by regeneron for a cash consideration of $4/share and a CVR link...
September 15, 2023, 6:32 pm
regeneron's pricing deal with federal government may have ‘far-reaching consequences,' analysts say
regeneron Pharmaceuticals Inc.'s REGN, +0.74% agreement with the federal government to limit the list p...
September 15, 2023, 8:40 am
Is regeneron stock fully valued at $820?
regeneron stock (NASDAQ: REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P...
September 11, 2023, 7:00 am